Veradigm Inc (MDRX)

$4.66 +0.01 (0.22%)
Market Cap 503.43M
Revenue (ttm) 588.02M
Net Income (ttm) -86.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -14.70%
Debt to Equity Ratio 0.20
Volume 5,200
Avg Vol 34,044
Day's Range N/A - N/A
Shares Out 108.27M
Stochastic %K 21%
Beta 0.71
Analysts Sell
Price Target $7.17

Company Profile

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS,...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 334 8534
Address:
222 Merchandise Mart Plaza, Suite 2024, Chicago, United States
LordWellesley
LordWellesley Aug. 28 at 5:51 AM
What an unloved, hidden gem is Veradigm $MDRX. Of course, it is taking them forever to reset their finances and the resulting delisting to the OTC sinbin doesn’t help. However, despite soaring accounting/consulting costs related to the reset they are generating 100 mln plus in free cashflow. Under a new CEO they are quietly building a strong position at the cutting edge of (performance based) medical practice efficiency, RWD generation and RWE analysis for the pharma world. By springtime the admin worries will finally be over and some simple arithmetic (120 mln fcf x 15 divided by 110 mln shares) will triple the current price. $SPY
0 · Reply
Whiskey1679
Whiskey1679 Aug. 23 at 7:59 PM
Whiskey's Penny Stock Picks out Monday morning! High Volume Stocks this past week: $XTPT $MDRX $NBBI $SDRC $QSEP
0 · Reply
LordWellesley
LordWellesley Aug. 18 at 9:03 PM
Veradigm $MDRX appoints Don Trigg as its new ceo. A healthcare venture cap background and ex Cerner (Oracle) in short: the plot thickens… $ORCL https://investor.veradigm.com/news-releases/news-release-details/veradigm-appoints-don-trigg-chief-executive-officer Veradigm Appoints Don Trigg as Chief Executive Officer | Veradigm Inc.
0 · Reply
LordWellesley
LordWellesley Jul. 23 at 4:10 AM
Experts call for action to fulfil the potential of real-world data in pharma research $IQV $ICLR $MDRX https://becarispublishing.com/digital-content/blog-post/experts-call-action-fulfil-potential-real-world-data-research
0 · Reply
LordWellesley
LordWellesley Jul. 17 at 10:22 AM
$MDRX quietly building up a wide moat.
0 · Reply
LordWellesley
LordWellesley Jun. 19 at 2:11 PM
$MDRX Veradigm to Release Business Update June 23rd and Host Investor Call June 24th.
0 · Reply
DonCorleone77
DonCorleone77 May. 12 at 12:16 PM
$MDRX Veradigm advances GLP-1 real-world evidence generation with AI Veradigm announced an advancement in the use of artificial intelligence to scale the generation of real-world evidence for GLP-1 receptor agonists, including semaglutide and tirzepatide. By applying AI to electronic health record deidentified data within the Veradigm Network, researchers can now surface rich, contextual insights-such as side effects, discontinuation reasons, and social determinants of health-that traditionally required intensive manual curation.
0 · Reply
LordWellesley
LordWellesley Apr. 22 at 11:28 PM
Veradigm $MDRX interim CEO Tom Langan is leaving the company with immediate effect. Does anyone know why? The press release only describes his severance package.
0 · Reply
LordWellesley
LordWellesley Apr. 18 at 1:44 AM
Veradigm $MDRX has fired @GrantThorntonUS for failing to spot sizeable accounting mistakes in the period 2019-2024. Leading to the current delisting. No doubt a hefty claim is in the making. @BDO_USA will take over.
0 · Reply
LordWellesley
LordWellesley Apr. 4 at 7:08 AM
Veradigm $MDRX interim CEO Tom Langan now owns 329,000 shares. Come on Tom make something happen (and yourself rich 🤑) !! https://investor.veradigm.com/static-files/f88e9901-c761-4557-9e35-623d411c39a4
0 · Reply
Latest News on MDRX
No data available.
LordWellesley
LordWellesley Aug. 28 at 5:51 AM
What an unloved, hidden gem is Veradigm $MDRX. Of course, it is taking them forever to reset their finances and the resulting delisting to the OTC sinbin doesn’t help. However, despite soaring accounting/consulting costs related to the reset they are generating 100 mln plus in free cashflow. Under a new CEO they are quietly building a strong position at the cutting edge of (performance based) medical practice efficiency, RWD generation and RWE analysis for the pharma world. By springtime the admin worries will finally be over and some simple arithmetic (120 mln fcf x 15 divided by 110 mln shares) will triple the current price. $SPY
0 · Reply
Whiskey1679
Whiskey1679 Aug. 23 at 7:59 PM
Whiskey's Penny Stock Picks out Monday morning! High Volume Stocks this past week: $XTPT $MDRX $NBBI $SDRC $QSEP
0 · Reply
LordWellesley
LordWellesley Aug. 18 at 9:03 PM
Veradigm $MDRX appoints Don Trigg as its new ceo. A healthcare venture cap background and ex Cerner (Oracle) in short: the plot thickens… $ORCL https://investor.veradigm.com/news-releases/news-release-details/veradigm-appoints-don-trigg-chief-executive-officer Veradigm Appoints Don Trigg as Chief Executive Officer | Veradigm Inc.
0 · Reply
LordWellesley
LordWellesley Jul. 23 at 4:10 AM
Experts call for action to fulfil the potential of real-world data in pharma research $IQV $ICLR $MDRX https://becarispublishing.com/digital-content/blog-post/experts-call-action-fulfil-potential-real-world-data-research
0 · Reply
LordWellesley
LordWellesley Jul. 17 at 10:22 AM
$MDRX quietly building up a wide moat.
0 · Reply
LordWellesley
LordWellesley Jun. 19 at 2:11 PM
$MDRX Veradigm to Release Business Update June 23rd and Host Investor Call June 24th.
0 · Reply
DonCorleone77
DonCorleone77 May. 12 at 12:16 PM
$MDRX Veradigm advances GLP-1 real-world evidence generation with AI Veradigm announced an advancement in the use of artificial intelligence to scale the generation of real-world evidence for GLP-1 receptor agonists, including semaglutide and tirzepatide. By applying AI to electronic health record deidentified data within the Veradigm Network, researchers can now surface rich, contextual insights-such as side effects, discontinuation reasons, and social determinants of health-that traditionally required intensive manual curation.
0 · Reply
LordWellesley
LordWellesley Apr. 22 at 11:28 PM
Veradigm $MDRX interim CEO Tom Langan is leaving the company with immediate effect. Does anyone know why? The press release only describes his severance package.
0 · Reply
LordWellesley
LordWellesley Apr. 18 at 1:44 AM
Veradigm $MDRX has fired @GrantThorntonUS for failing to spot sizeable accounting mistakes in the period 2019-2024. Leading to the current delisting. No doubt a hefty claim is in the making. @BDO_USA will take over.
0 · Reply
LordWellesley
LordWellesley Apr. 4 at 7:08 AM
Veradigm $MDRX interim CEO Tom Langan now owns 329,000 shares. Come on Tom make something happen (and yourself rich 🤑) !! https://investor.veradigm.com/static-files/f88e9901-c761-4557-9e35-623d411c39a4
0 · Reply
LordWellesley
LordWellesley Mar. 14 at 7:14 AM
Finally some movement re the updated Veradigm results and outlook but the message is vague. No mention even of the ‘22 etc. repairs. What’s brewing? Let’s find out. https://investor.veradigm.com/node/25121/pdf $MDRX
0 · Reply
IOMASS
IOMASS Mar. 13 at 4:21 PM
$MDRX Something/someone out there pushing some volume - a number of block trades - maybe near-term earnings release (finally) - we'll see...
1 · Reply
LordWellesley
LordWellesley Feb. 25 at 11:00 AM
Don’t fall into this greed trap Veradigm. https://www.linkedin.com/posts/activity-7299925500821389312-5C7x?utm_medium=ios_app&rcm=ACoAAAITHYMBRtFnjNkFrVUgIpka1TkAdtue6Oc&utm_source=social_share_send&utm_campaign=copy_link $MDRX
0 · Reply
LordWellesley
LordWellesley Feb. 21 at 8:33 AM
Veradigm will add four new directors to its board in an agreement with investor Kent Lake Capital. This feels like a much needed boost to investor confidence but the proof is in the… SEC filing of results and the contents of the analysts call. $MDRX https://search.app/P5w7oSfCzLk7pxxg8
1 · Reply
LordWellesley
LordWellesley Feb. 20 at 10:28 PM
Veradigm announces board changes ‘requested’ by activist group Kent Lake. $MDRX https://investor.veradigm.com/news-releases/news-release-details/veradigm-announces-board-expansion-and-changes
0 · Reply
LordWellesley
LordWellesley Feb. 18 at 2:54 PM
Let #Gemini answer my question about the viability and marketability of the Veradigm RWD databases: https://gemini.google.com/app/495633c23d6a9319 $MDRX
0 · Reply
LordWellesley
LordWellesley Feb. 18 at 2:02 PM
And is there a sizeable and defendable market for these Veradigm RWD domains? $MDRX
1 · Reply
LordWellesley
LordWellesley Feb. 18 at 1:24 PM
And the Veradigm beat goes on: https://investor.veradigm.com/news-releases/news-release-details/veradigm-introduces-cardiometabolic-clinical-registry-datasets $MDRX
0 · Reply
hunter33
hunter33 Jan. 31 at 3:41 PM
$MDRX why did this stock go to the expert market?
1 · Reply
LordWellesley
LordWellesley Jan. 31 at 12:31 PM
More Veradigm bright spots: - Return to regular result filing will mean Nasdaq relisting approx April - Finally an analyst call to explain what’s going on. - Rather have one company that combines EHR income and RWD data sales. Surprised that no suitor saw the value of that combination. - At a PSR of 1.0 (low) $MDRX is worth $8.00 no don’t let a low opening fool you.
0 · Reply
LordWellesley
LordWellesley Jan. 31 at 1:07 AM
$MDRX On the positive side: a return to regular financial reporting is in sight.
0 · Reply
IOMASS
IOMASS Jan. 30 at 9:30 PM
$MDRX well IF the financials are ok and IF MDRX gets re-listed on NASDAQ then maybe I can save face - what a saga…
2 · Reply